1-(4-甲氧基苯基)-2-丁酮 | 53917-01-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 中文名称: 1-(4-甲氧基苯基)-2-丁酮
• 英文名称: 1-(4-methoxyphenyl)butan-2-one
• CAS: 53917-01-4
• 化学式: C₁₁H₁₄O₂
• 分子量: 178.231
• InChiKey: MUUSKLMAQKVLKY-UHFFFAOYSA-N

物化性质

• 沸点：
  265-270 °C
• 密度：
  1.010

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 海关编码：
  2914509090

反应信息

• 作为反应物：
  描述：

  1-(4-甲氧基苯基)-2-丁酮 在 咪唑 、 4-二甲氨基吡啶 、 正丁基锂 、 三溴化硼 、 sodium hydride 、 O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate 作用下， 以 四氢呋喃 、 正己烷 、 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 30.58h， 生成 (+/-)-N-(4-(2-(dimethylamino)ethoxy)phenyl)-3-ethyl-6-triisopropylsiloxy-2-(4-triisopropylsiloxyphenyl)-1H-indene-1-carboxamide
  参考文献：
  名称：

  Differential Response of Estrogen Receptor Subtypes to 1,3-Diarylindene and 2,3-Diarylindene Ligands

  摘要：

  Estrogen receptors (ERs) control transcription of genes important for normal human development and reproduction. The signaling networks are complex, and there is a need for a molecular level understanding of the roles of receptor subtypes ER alpha and ER beta in normal physiology and as therapeutic targets. We synthesized two series of ER ligands, based on a common indene scaffold, in an attempt to develop compounds that can selectively modulate ER-mediated transcription. The 3-ethyl-1,2-diarylindenes, utilizing an amide linker for the 1-aryl extension, bind weakly to the ERs. The 2,3-diarylindenes bind with high affinity to the ER subtypes and demonstrate a range of different biological activities, both in transcriptional reporter gene assays and inhibition of estradiol-stimulated proliferation of MCF-7 cells. Several ligands differentiate between ER alpha and ER beta subtypes at an estrogen response element (ERE), displaying various levels of partial to full agonist activity at ER alpha, while antagonizing estradiol action at ER beta.

  DOI：

  10.1021/jm050226i
• 作为产物：
  描述：

  对甲氧基苯乙醇 在 pyridine-SO3 complex 、 戴斯-马丁氧化剂 、 三乙胺 作用下， 以 四氢呋喃 、 二氯甲烷 、 二甲基亚砜 为溶剂， 反应 12.5h， 生成 1-(4-甲氧基苯基)-2-丁酮
  参考文献：
  名称：

  WO2007/102679

  摘要：

  公开号：

文献信息

• HYDROXYAMIC ANALOGS AS HEPATITIS C VIRUS SERINE PROTEASE INHIBITOR
  申请人：Gai Yonghua

  公开号：US20090123423A1

  公开（公告）日：2009-05-14

  The present invention relates to compounds of Formula I, or a pharmaceutically acceptable salt, ester, or prodrug, thereof: which inhibit serine protease activity, particularly the activity of hepatitis C virus (HCV) NS3-NS4A protease. Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

  本发明涉及式I化合物，或其药用可接受的盐、酯或前药：其抑制丝氨酸蛋白酶活性，尤其是丙型肝炎病毒（HCV）NS3-NS4A蛋白酶的活性。因此，本发明的化合物干扰丙型肝炎病毒的生命周期，并且还可用作抗病毒剂。本发明进一步涉及包含前述化合物的药物组合物，用于给患有HCV感染的对象服用。本发明还涉及通过管理包含本发明化合物的药物组合物来治疗对象中的HCV感染的方法。
• Separation and Identification of Volatile Components in the Fermentation Broth of Trichoderma atroviride by Solid-Phase Extraction and Gas Chromatography--Mass Spectrometry
  作者：A. Keszler、E. Forgacs、L. Kotai、J. A. Vizcaino、E. Monte、I. Garcia-Acha

  DOI：10.1093/chromsci/38.10.421

  日期：2000.10.1

  A preseparated fermentation broth of Trichoderma atroviride strain 11 is analyzed by gas chromatography followed by mass-spectral detection using a Finnigan MAT GCQ apparatus. After preseparation in a C18 and a silica gel column, nineteen pyrone and dioxolane derivatives and two aliphatic esters are obtained, respectively. Among these, the four dioxolane derivatives have not been identified previously

  通过气相色谱分析随后分离的阿魏木霉菌株11的发酵肉汤，然后使用Finnigan MAT GCQ仪器进行质谱检测。在C18和硅胶柱中进行预分离后，分别获得十九个吡喃酮和二氧戊环衍生物以及两种脂族酯。其中，四种二氧戊环衍生物先前尚未鉴定。发现主要成分为5,5'-二甲基-2H-吡喃-2-on。用于确定保留时间和峰面积（以离子数测量）的相对标准偏差分别为0.1％和4.5％。
• Regioselective Isomerization of 2,3-Disubstituted Epoxides to Ketones: An Alternative to the Wacker Oxidation of Internal Alkenes
  作者：Jessica R. Lamb、Michael Mulzer、Anne M. LaPointe、Geoffrey W. Coates

  DOI：10.1021/jacs.5b10419

  日期：2015.12.2

  trans-alkenes followed by a mild and highly regioselective isomerization to give the major ketone isomers in 66-98% yield. Preliminary kinetics and isotope labeling studies suggest epoxide ring opening as the turnover limiting step in our proposed mechanism. A similar catalytic system was applied to the kinetic resolution of select trans-epoxides to give synthetically useful selectivity factors of 17-23

  我们报告了内烯烃的瓦克氧化的替代途径，包括反式烯烃的环氧化，然后是温和且高度区域选择性的异构化，以 66-98% 的产率得到主要的酮异构体。初步动力学和同位素标记研究表明环氧化物开环是我们提出的机制中的周转限制步骤。将类似的催化系统应用于选择的反式环氧化物的动力学拆分，为苄基取代的底物提供 17-23 的合成有用选择性因子。
• SULFONAMIDE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALT THEREOF
  申请人：UNIVERSITY OF TSUKUBA

  公开号：US20180179151A1

  公开（公告）日：2018-06-28

  The present invention aims to provide a novel low-molecular-weight compound exhibiting an orexin receptor agonist activity and expected to be useful as a prophylactic or therapeutic agent for narcolepsy and the like. The present invention provides a compound represented by the formula (I): wherein each symbol is as defined in the description, or a pharmaceutically acceptable acid addition salt thereof, which has an orexin receptor agonist activity, and an orexin receptor agonist containing the compound or a pharmaceutically acceptable acid addition salt thereof.

  本发明旨在提供一种新型低分子量化合物，表现出促进俄利班受体活性，并且预计可用作嗜睡症等疾病的预防或治疗药物。本发明提供一种由式(I)表示的化合物：其中每个符号如描述中定义，或其药用可接受的酸盐，具有促进俄利班受体活性，并且含有该化合物或其药用可接受的酸盐的俄利班受体激动剂。
• C–H Alkylation of Aldehydes by Merging TBADT Hydrogen Atom Transfer with Nickel Catalysis
  作者：Vetrivelan Murugesan、Anirban Ganguly、Ardra Karthika、Ramesh Rasappan

  DOI：10.1021/acs.orglett.1c01716

  日期：2021.7.16

  functionalization is a challenging but powerful tool in organic synthesis. Polarity-matched and sterically controlled hydrogen atom transfer (HAT) provides an excellent opportunity for site-selective functionalization. As such, the dual Ni/photoredox system was successfully employed to generate acyl radicals from aldehydes via selective formyl C–H activation and subsequently cross-coupled to generate ketones, a ubiquitous

  催化剂控制的位点选择性 C-H 功能化是有机合成中具有挑战性但功能强大的工具。极性匹配和空间控制的氢原子转移 (HAT) 为位点选择性功能化提供了极好的机会。因此，双镍/光氧化还原系统成功地用于通过选择性甲酰基 C-H 活化从醛生成酰基自由基，随后交叉偶联生成酮，这是绝大多数天然和生物活性分子中普遍存在的结构基序。然而，仅开发了少数限制使用芳基卤化物的例子。鉴于胺的广泛可用性，我们首次使用经济的镍和 TBADT 催化剂通过 C-N 键断裂开发了交叉偶联反应。一系列烷基和芳基醛与苄基和烯丙基吡啶盐交叉偶联，以提供具有广谱官能团耐受性的酮。即使在α-亚甲基羰基或α-氨基/氧基亚甲基存在下，也获得了对甲酰基C-H键的高区域选择性。

表征谱图